Euroapi SAS
PAR:EAPI
Euroapi SAS
Free Cash Flow
Euroapi SAS
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
E
|
Euroapi SAS
PAR:EAPI
|
Free Cash Flow
€14.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Sanofi SA
PAR:SAN
|
Free Cash Flow
€4.1B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
|
![]() |
Ipsen SA
PAR:IPN
|
Free Cash Flow
€133m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-2%
|
|
![]() |
Vetoquinol SA
PAR:VETO
|
Free Cash Flow
€70.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
27%
|
CAGR 10-Years
11%
|
|
![]() |
Virbac SA
PAR:VIRP
|
Free Cash Flow
€133.5m
|
CAGR 3-Years
17%
|
CAGR 5-Years
4%
|
CAGR 10-Years
14%
|
|
![]() |
Medincell SA
PAR:MEDCL
|
Free Cash Flow
€20.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Euroapi SAS
Glance View
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
See Also
What is Euroapi SAS's Free Cash Flow?
Free Cash Flow
14.8m
EUR
Based on the financial report for Dec 31, 2024, Euroapi SAS's Free Cash Flow amounts to 14.8m EUR.